|
University of California, San Diego |
Tariq Rana |
Quest - Discovery Stage Research Projects |
Development of COVID-19 Antiviral Therapy Using Human iPSC-Derived Lung Organoids |
$250,000 |
|
City of Hope, Beckman Research Institute |
Yanhong Shi |
Quest - Discovery Stage Research Projects |
Combating COVID-19 using human PSC-derived NK cells |
$249,998 |
|
University of California, Berkeley |
Kevin Healy |
Progression Award - Discovery Stage Research Projects |
Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy |
$224,500 |
|
University of California, Los Angeles |
Lili Yang |
Discovery Research Projects |
Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells |
$250,000 |
|
University of California, San Diego |
Karen Christman |
Discovery Research Projects |
Pro-healing biomaterial for treating lung inflammation associated with COVID-19 |
$221,758 |
|
Sanford Burnham Prebys Medical Discovery Institute |
Evan Snyder |
Discovery Research Projects |
Using hiPSC-derived lung organoids, a clinically-relevant system, to validate & winnow a list of approved drugs that inhibit SARS-CoV-2 cytopathy |
$228,229 |
|
University of California, San Diego |
Steve Dowdy |
Discovery Research Projects |
Development of Anti-COVID RNAi Therapeutics Using Human iPSC-Derived Alveolar Epithelial Cells |
$150,000 |
|
Celularity Inc. |
William van der Touw |
Clinical Trial Stage Projects |
A phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 |
$315,000 |
|
University of Southern California |
PREET Chaudhary |
Discovery Research Projects |
Chimeric Antigen Receptor Targeting Spike Glycoprotein of SARS-cov2 |
$248,125 |
|
University of California, Los Angeles |
Song Li |
Discovery Research Projects |
Biomaterial vaccine to enhance the formation of SARS-CoV-2-specific T memory stem cells |
$149,916 |
|
University of California, Los Angeles |
Vaithilingaraja Arumugaswami |
Therapeutic Translational Research Projects |
COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage |
$349,999 |
|
Stanford University |
Helen Blau |
Discovery Research Projects |
Application of PGE2/BPV, a muscle stem cell targeting therapeutic, to the treatment of COVID-19 associated diaphragm atrophy |
$149,996 |
|
Stanford University |
Albert Wong |
Discovery Research Projects |
Identifying HLA Class I Restricted Peptides That Induce CD8+ T Cells Against SARS-CoV-2 |
$249,999 |
|
City of Hope, Beckman Research Institute |
Jianhua Yu |
Discovery Research Projects |
Persistent Off-the-Shelf meACE2-CAR-IL-15 NK Cells Derived from CD34(+) Cord Blood Stem Cells to Prevent and Treat COVID-19 |
$150,000 |
|
Scripps Research Institute |
Stuart Lipton |
Discovery Research Projects |
Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage |
$150,000 |
|
University of Southern California |
Justin Ichida |
Discovery Research Projects |
Development of a novel PIKFYVE kinase inhibitor for the treatment of COVID-19 |
$140,067 |
|
University of California, San Francisco |
Michael Matthay |
Clinical Trial Stage Projects |
Mesenchymal Stromal Cells for ARDS (COVID positive and COVID negative) |
$701,049 |
|
University of California, Los Angeles |
Brigitte Gomperts |
Discovery Research Projects |
Identifying a lead compound for COVID19 using high throughput screening with lung stem cell organoids |
$149,998 |
|
University of California, Los Angeles |
Gay Crooks |
Discovery Research Projects |
Stem cell-based rapid identification of SARS-CoV-2 T cell epitopes and T cell receptors for therapeutic use |
$126,692 |
|
City of Hope, Beckman Research Institute |
John Zaia |
Clinical Trial Stage Projects |
Evaluation and Characterization of SARS-CoV-2 Antibody in Convalescent Volunteer Plasma Donors for Potential Therapeutic Use |
$999,999 |
